(Date:11/30/2009)...Dec. 1 Low-dose radiation from ann...er risk in women with genetic or familial predispo...ented today at the annual meeting of the Radiologi...omen at high risk for breast cancer, screening is ...aken when considering mammography for screening yo...
(Date:11/30/2009)..., Pa., Nov. 30 VitaminSp... has elected William "Bill" R. Fields to the Boar...9, is Chairman of Intersource Co. Ltd. Mr. Fields ...ously, Mr. Fields served as Chairman and Chief Exe...02 to 2003, President and Chief Executive Officer ...
(Date:11/30/2009)...N, Nov. 30 At a briefin... (LCAO) and the Consortium for Citizens with Disab... of Public Policy and Advocacy for NCOA, called on...ation responds to the growing crisis in long-term ... "Millions of seniors, after working hard all thei...
(Date:11/30/2009)...Nov. 30 /PRNewswire-FirstCall/ - AIM Health Group ...y integrated health care company, announced today ...ed September 30, 2009 (the "Quarter") increased to... At the same time EBITDA(1) increased 290% to $910...s. The Company also announced that revenues increa...
(Date:11/30/2009)..., Nov. 30 Major League Baseball,...as City Royals and recently acquired by the Chicag...74;). The award is given annually to a Major Leagu...courage and dedication of baseball great Fred Hutc...-year-old Redlands, Calif., native made his MLB de...
Breaking Medicine News(10 mins):Health News:Mammography May Increase Breast Cancer Risk in Some High-Risk Women 2Health News:Mammography May Increase Breast Cancer Risk in Some High-Risk Women 3Health News:VitaminSpice Elects Bill Fields to the Board of Directors 2Health News:NCOA, Bedlin Brief Leading Aging Organizations on Health Care Reform, Needed Long-Term Care Provisions 2Health News:AIM Health Group Inc. continues increased quarterly profits 2Health News:AIM Health Group Inc. continues increased quarterly profits 3Health News:AIM Health Group Inc. continues increased quarterly profits 4Health News:Mark Teahen Named 2009 Hutch Award Winner 2... jury awarded $32 million for the family of a 71-y...iller Vioxx. // But this will be greatly reduced b...t is a weak case against Vioxx maker Merck & Co. I...amages, but the latter will be cut to no more than...
... Neurosurgery and Psychiatry highlights a case whe...after being exposed to high levels of aluminum cou...she died in 2004.
Chris Exley, of Keele Univers...ped into the water supply at Camelford, in north C...
...rol and Prevention (CDC) it was noted that a numbe...ne diseases in the month of May, June and July. //...disease caused due to tick bites. Statistics show ...derreported. It is transmitted through the bite of...
...er enzyme in sepsis increases the bodys vulnerabil...a deficiency confers strong resistance to sepsis. ...n and innate immunity in humans.
"The results ...ominal infections to be better resolved. It's know...
...Kevin Gosling donated a part of his liver to a 5-y... incurable liver disease //. He further stated tha...complete stranger or about putting his own life at...mental in shaping the decision of this 46-year old...
... about the TB X-Ray screening arangements at the p...e is the screening for Tuberculosis infections at ...y from countries that are reeling under the TB on...eed alarming as the remaining 73% go undetected. ...
Other Medicine News:Health News:Merck in the Dock Due To Vioxx 2Health News:Exposure To High Aluminum Levels In Tap Water Lead To Rare Form Of Alzheimers 2Health News:Sepsis risk increased due to the absence of one key enzyme 2Health News:46-Year-Old Canada Man Donates A Part Of His Liver To A Complete Stranger 2(Date:11/30/2009)... , SAN CARLOS, Calif., Nov. 30 /PRNewswire-Fir...day announced the promotion of Lorianne Masuoka, M...icer. Dr. Masuoka will report directly to Nektar,... Robin. ,, "Lorianne,s outstanding leadership...ies have been instrumental in rapidly advancing Ne...
(Date:11/30/2009)... , PRINCETON, N.J., Nov. 30 /PRNewswire-FirstCa... that it will present at the Piper Jaffray 21st An... 2, 2009 at 1:30 p.m. (ET). Investors may access ....com . In order to register and download any nece..., Covance, with headquarters in Princeton, New J...
(Date:11/30/2009)... , CHARLESTON, S.C., Nov. 30 ...m, "SEBIO 2009", will be held at the Charleston Pl...SC, on December 3-4, 2009. Dr. Cheryl Liljestrand...atent attorneys with Stipkala LLC, will attend. S...e companies, investors, scientists, entrepreneurs,...
Breaking Medicine Technology:Nektar Therapeutics Promotes Lorianne Masuoka, M.D. to Senior Vice President and Chief Medical Officer 2Nektar Therapeutics Promotes Lorianne Masuoka, M.D. to Senior Vice President and Chief Medical Officer 3Crohn 26apos 3Bs 26amp 3B Colitis Foundation Launches New Web Site to Commence Take Steps Walk Season 3A Walkers Can Take the Step that Counts Using 58787 1Crohn 26apos 3Bs 26amp 3B Colitis Foundation Launches New Web Site to Commence Take Steps Walk Season 3A Walkers Can Take the Step that Counts Using 58787 2Crohn 26apos 3Bs 26amp 3B Colitis Foundation Launches New Web Site to Commence Take Steps Walk Season 3A Walkers Can Take the Step that Counts Using 58787 3ADA Culminates Yearlong 150th Anniversary Observance at Its 150th Annual Session 58785 1ADA Culminates Yearlong 150th Anniversary Observance at Its 150th Annual Session 58785 2ADA Culminates Yearlong 150th Anniversary Observance at Its 150th Annual Session 58785 3Thirty one Minnesota Hospitals Win Patient Safety Awards 58783 1Thirty one Minnesota Hospitals Win Patient Safety Awards 58783 2...land, May 18 , - New Alliance a Key Step for ...c Antibodies , Oxford BioTherapeutics (OBT) to...Kline to discover, develop and commercialise novel...ary, metastatic and recurring forms of,cancer. , ...body therapies against,selected OBT targets. In pa...
...., May 17 Essentialis Inc, a clinical stage pharm... primary endpoint of statistically significant tri... of DCCR in dyslipidemic patients. The study encom...and mixed dyslipidemia and included normal weight,...without hypertension. , , The randomized, double-...
Other Medicine Technology:Oxford BioTherapeutics and GlaxoSmithKline Form Strategic Alliance to Develop Novel Cancer Therapeutic Antibodies 2Oxford BioTherapeutics and GlaxoSmithKline Form Strategic Alliance to Develop Novel Cancer Therapeutic Antibodies 3Essentialis Meets Primary Endpoint in Phase 2b Trial of DCCR for Treatment of Hypertriglyceridemia and is Granted Extensive Patent Coverage in the US 2Essentialis Meets Primary Endpoint in Phase 2b Trial of DCCR for Treatment of Hypertriglyceridemia and is Granted Extensive Patent Coverage in the US 3...,Cynergy III allows you to create a true modular ...s combination,of pulse dye and Nd:YAG, and add-o...st exciting innovation in dermatology,in years. ...,wider variety of telangiactasias, vascular and ...
...re your system. You define the type and breadth of...um solution. We scale the system to your budget an...our needs because we listen. The result? Kortex. T...ives you what you demand: unequalled reliability, ...
...emistry-immuno analyzer for small- to medium-size ...alty analyzer for larger institutions. Automate an...s 122 test menu including chemistry, urine chemist...sts for therapeutic drug monitoring, drugs-of-abus...
Total Intact PTH IRMA
Medicine Products: